231 related articles for article (PubMed ID: 20681410)
1. Allelic loss of the ING gene family loci is a frequent event in ameloblastoma.
Borkosky SS; Gunduz M; Beder L; Tsujigiwa H; Tamamura R; Gunduz E; Katase N; Rodriguez AP; Sasaki A; Nagai N; Nagatsuka H
Oncol Res; 2010; 18(10):509-18. PubMed ID: 20681410
[TBL] [Abstract][Full Text] [Related]
2. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
Doyon Y; Cayrou C; Ullah M; Landry AJ; Côté V; Selleck W; Lane WS; Tan S; Yang XJ; Côté J
Mol Cell; 2006 Jan; 21(1):51-64. PubMed ID: 16387653
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.
Igci M; Arslan A; Erturhan S; Igci YZ; Pala E; Gogebakan B; Karakok M; Cakmak EA; Cengiz B
Mol Biol Rep; 2015 Feb; 42(2):507-16. PubMed ID: 25324173
[TBL] [Abstract][Full Text] [Related]
4. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
[TBL] [Abstract][Full Text] [Related]
5. [Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].
Wei JB; Chen LS; Gao F
Ai Zheng; 2005 Feb; 24(2):141-4. PubMed ID: 15694021
[TBL] [Abstract][Full Text] [Related]
6. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss of tumor suppressor genes in ameloblastic tumors.
Nodit L; Barnes L; Childers E; Finkelstein S; Swalsky P; Hunt J
Mod Pathol; 2004 Sep; 17(9):1062-7. PubMed ID: 15133474
[TBL] [Abstract][Full Text] [Related]
8. The ING tumor suppressor genes: status in human tumors.
Guérillon C; Bigot N; Pedeux R
Cancer Lett; 2014 Apr; 345(1):1-16. PubMed ID: 24333729
[TBL] [Abstract][Full Text] [Related]
9. The new tumor suppressor genes ING: genomic structure and status in cancer.
Ythier D; Larrieu D; Brambilla C; Brambilla E; Pedeux R
Int J Cancer; 2008 Oct; 123(7):1483-90. PubMed ID: 18636562
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of the PTCH gene in ameloblastoma.
Farias LC; Gomes CC; Brito JA; Galvão CF; Diniz MG; de Castro WH; Bernardes Vde F; De Marco LA; Gomez RS
Hum Pathol; 2012 Aug; 43(8):1229-33. PubMed ID: 22221699
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
[TBL] [Abstract][Full Text] [Related]
13. Phylogenetic analysis of the ING family of PHD finger proteins.
He GH; Helbing CC; Wagner MJ; Sensen CW; Riabowol K
Mol Biol Evol; 2005 Jan; 22(1):104-16. PubMed ID: 15356280
[TBL] [Abstract][Full Text] [Related]
14. DNA damage response activation and cell cycle dysregulation in infiltrative ameloblastomas: A proposed model for ameloblastoma tumor evolution.
Diniz MG; Guimarães BVA; Pereira NB; de Menezes GHF; Gomes CC; Gomez RS
Exp Mol Pathol; 2017 Jun; 102(3):391-395. PubMed ID: 28454892
[No Abstract] [Full Text] [Related]
15. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
16. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
18. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
Sanchez-Cespedes M; Okami K; Cairns P; Sidransky D
Genes Chromosomes Cancer; 2000 Mar; 27(3):319-22. PubMed ID: 10679922
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues.
Walzak AA; Veldhoen N; Feng X; Riabowol K; Helbing CC
Exp Cell Res; 2008 Jan; 314(2):273-85. PubMed ID: 17720155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
